Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
McKinsey
Express Scripts
AstraZeneca
Merck

Last Updated: January 24, 2020

DrugPatentWatch Database Preview

CEFOTAN Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

When do Cefotan patents expire, and when can generic versions of Cefotan launch?

Cefotan is a drug marketed by Teligent and Teligent Pharma Inc and is included in three NDAs.

The generic ingredient in CEFOTAN is cefotetan disodium. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the cefotetan disodium profile page.

Summary for CEFOTAN
US Patents:0
Applicants:2
NDAs:3
Suppliers / Packagers: 1
Bulk Api Vendors: 24
Patent Applications: 780
DailyMed Link:CEFOTAN at DailyMed
Drug patent expirations by year for CEFOTAN
Pharmacology for CEFOTAN
Synonyms for CEFOTAN
(6R,7S)-4-((2-Carboxy-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-7-yl)carbamoyl)-1,3-dithietane-delta(sup 2,alpha)-malonamic acid, disodium salt
(6R,7S)-7-(4-(Carbamoylcarboxymethylene)-1,3-dithietane-2-carboxamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, disodium salt
0GXP746VXB
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((4-(2-amino-1-carboxy-2-oxoethyl)-1,3-dithietan-2-yl)carbonyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, disodium salt, (6R-cis)-
69712-56-7 (Parent)
74356-00-6
AC1L1E30
AKOS025311215
AN-37204
Apatef
C14007
C17H15N7O8S4.2Na
C17H17N7O8S4.2Na
Cefotan (TN)
CEFOTAN IN PLASTIC CONTAINER
Cefotetan and dextrose in duplex container
CEFOTETAN DISODIUM
Cefotetan disodium (USP)
Cefotetan disodium [USAN:USP]
Cefotetan disodium [USAN]
Cefotetan disodium salt
Cefotetan disodium, Antibiotic for Culture Media Use Only
cefotetan sodium
Cefotetan sodium (JAN)
Ceftenon
Cepan
CHEBI:34617
CHEMBL1201098
D02228
Darvilen
disodium (6R,7S)-7-({[4-(2-amino-1-carboxylato-2-oxoethylidene)-1,3-dithietan-2-yl]carbonyl}amino)-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
disodium (6R,7S)-7-[[4-(1-amino-3-oxido-1,3-dioxopropan-2-ylidene)-1,3-dithietane-2-carbonyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
disodium (6R,7S)-7-[[4-(2-amino-1-carboxylato-2-oxo-ethylidene)-1,3-dithietane-2-carbonyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
Disodium (7R)-7-[[4-(carbamoyl-carboxylato-methylidene)-1,3-dithietane-2-carbonyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
disodium 7beta-({[4-(2-amino-1-carboxylato-2-oxoethylidene)-1,3-dithietan-2-yl]carbonyl}amino)-7alpha-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-3,4-didehydrocepham-4-carboxylate
Disodium(7R)-7-[[4-(carbamoyl-carboxylato-methylidene)-1,3-dithietane-2-carbonyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
EINECS 277-834-9
FT-0645368
ICI 156834 disodium
ICI-156834
LS-149943
M153
PubChem19005
SCHEMBL40794
sodium (6R,7S)-7-(4-(2-amino-1-carboxylato-2-oxoethylidene)-1,3-dithietane-2-carboxamido)-7-methoxy-3-((1-methyl-1H-tetrazol-5-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
UNII-0GXP746VXB
Yamatetan
YM 09330
YM-09330

US Patents and Regulatory Information for CEFOTAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teligent CEFOTAN cefotetan disodium INJECTABLE;INJECTION 050588-001 Dec 27, 1985 AP RX Yes No   Start Trial   Start Trial   Start Trial
Teligent CEFOTAN IN PLASTIC CONTAINER cefotetan disodium INJECTABLE;INJECTION 050694-001 Jul 30, 1993 DISCN No No   Start Trial   Start Trial   Start Trial
Teligent Pharma Inc CEFOTAN cefotetan disodium INJECTABLE;INJECTION 063293-001 Apr 29, 1993 DISCN No No   Start Trial   Start Trial   Start Trial
Teligent CEFOTAN cefotetan disodium INJECTABLE;INJECTION 050588-002 Dec 27, 1985 AP RX Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
Mallinckrodt
Colorcon
Boehringer Ingelheim
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.